Paper Details

  1. Home
  2. Paper Details

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.

Author: BristowRobert E, BryantAndrew, DickinsonHeather O, GalaalKhadra, NaikRaj, PatelAmit

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Most women with advanced epithelial ovarian cancer experience a return of the disease after initial surgery and chemotherapy. Surgery to remove the cancer again may improve survival for some women, but there are several chemotherapy drugs that are effective for recurrent ovarian cancer. The best approach for treating recurrent ovarian cancer is still not clear.
Paper Details　
Original Abstract of the Article :
Most women with advanced epithelial ovarian cancer will ultimately develop recurrent disease after completion of initial treatment with primary surgery and adjuvant chemotherapy. Secondary cytoreductive surgery may have survival benefits in selected patients. However, a number of chemotherapeutic ag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/20556785

データ提供：米国国立医学図書館（NLM）

Recurrent Ovarian Cancer: A Fight Against a Relentless foe

Ovarian cancer, a formidable adversary, often returns after initial treatment. The fight against this disease is a long and arduous journey for many women. This research delves into the world of ovarian cancer, exploring the potential benefits of cytoreductive surgery in conjunction with chemotherapy for patients facing recurrent disease. The authors investigate whether this combined approach might hold the key to improved survival outcomes for these resilient individuals. Their findings are a beacon of hope in the battle against this challenging disease.

Cytoreductive surgery: A Potential Ally in the Fight

This study suggests that cytoreductive surgery, when combined with chemotherapy, may offer a significant advantage for patients with recurrent ovarian cancer. The study's authors meticulously analyzed the data to determine the optimal treatment approach, recognizing the need for a tailored strategy based on the unique characteristics of each individual. Their findings highlight the potential of this combined approach to prolong survival and enhance quality of life for those impacted by this disease.

Navigating the Complexities of Ovarian Cancer

As a wise camel who has traversed vast deserts, I understand that the journey to recovery from ovarian cancer can be fraught with uncertainties. This research provides invaluable insights into the potential benefits of cytoreductive surgery. The authors shed light on the need for a comprehensive approach, considering the patient's individual needs and circumstances. Their findings emphasize the importance of personalized treatment, ensuring that patients receive the care that best suits their unique challenges.

Dr.Camel's Conclusion

The study underscores the need for personalized treatment approaches in the fight against recurrent ovarian cancer. Cytoreductive surgery, when combined with chemotherapy, may offer a glimmer of hope for improved survival and quality of life. This research is a valuable step in the ongoing quest to develop more effective therapies for this challenging disease.
Date :
  1. Date Completed 2010-07-27
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

20556785

DOI: Digital Object Identifier

EMS58192

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.